Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study

Clinical trial NCT02371499 · COMPLETED

Trial details

NCT number: NCT02371499
Sponsor: SOFAR S.p.A.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2014-12-01
Primary completion: 2015-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.